Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism

Lisa Eggebrecht, Juergen H. Prochaska, Sven-Oliver Troebs, Soeren Schwuchow-Thonke, Sebastian Goebel, Simon Diestelmeier, Andreas Schulz, Natalie Arnold, Marina Panova-Noeva, Thomas Koeck, Steffen Rapp, Tommaso Gori, Karl J. Lackner, Hugo ten Cate, Thomas Muenzel, Philipp Sebastian Wild*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)787-796
Number of pages10
JournalClinical research in cardiology
Volume108
Issue number7
DOIs
Publication statusPublished - Jul 2019

Keywords

  • Anticoagulation
  • Direct oral anticoagulants
  • Vitamin K antagonist
  • Cardiac function
  • Lipids and lipid protein metabolism
  • DIRECT THROMBIN INHIBITION
  • FACTOR-XA
  • ATRIAL-FIBRILLATION
  • DABIGATRAN ETEXILATE
  • RIVAROXABAN
  • PROGRESSION
  • RISK
  • FIBROBLASTS
  • WARFARIN
  • DISEASE

Cite this

Eggebrecht, L., Prochaska, J. H., Troebs, S-O., Schwuchow-Thonke, S., Goebel, S., Diestelmeier, S., Schulz, A., Arnold, N., Panova-Noeva, M., Koeck, T., Rapp, S., Gori, T., Lackner, K. J., ten Cate, H., Muenzel, T., & Wild, P. S. (2019). Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism. Clinical research in cardiology, 108(7), 787-796. https://doi.org/10.1007/s00392-018-1408-y